A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 123.38
GOOG 628.00
MSFT 45.34
FB 95.29
BAC 17.88

Recently Added

CPRX 5.23
ACE 107.62
CRQE 0.00
HZNP 38.32
PMD 12.11

Gaining Speed

ACE 107.62
CPRX 5.23
CPB 49.00
MNKD 4.82
EXEL 5.41

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!